Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $52.86 million. The enterprise value is $36.73 million.

Market Cap	52.86M
Enterprise Value	36.73M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

GANX has 25.54 million shares outstanding. The number of shares has increased by 35.04% in one year.

Shares Outstanding	25.54M
Shares Change (YoY)	+35.04%
Shares Change (QoQ)	+6.88%
Owned by Insiders (%)	5.09%
Owned by Institutions (%)	11.90%
Float	24.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.42
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.07.

Current Ratio	2.84
Quick Ratio	2.64
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -188.83% and return on invested capital (ROIC) is -110.06%.

Return on Equity (ROE)	-188.83%
Return on Assets (ROA)	-72.96%
Return on Capital (ROIC)	-110.06%
Revenue Per Employee	n/a
Profits Per Employee	-$674,985
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GANX has paid $57,041 in taxes.

Income Tax	57,041
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.87% in the last 52 weeks. The beta is 0.34, so GANX's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-27.87%
50-Day Moving Average	1.86
200-Day Moving Average	2.54
Relative Strength Index (RSI)	44.85
Average Volume (20 Days)	398,492

Short Selling Information

The latest short interest is 572,006, so 2.24% of the outstanding shares have been sold short.

Short Interest	572,006
Short Previous Month	654,274
Short % of Shares Out	2.24%
Short % of Float	2.36%
Short Ratio (days to cover)	1.60

Income Statement

Revenue	n/a
Gross Profit	-11.44M
Operating Income	-21.86M
Pretax Income	-21.54M
Net Income	-21.60M
EBITDA	-21.82M
EBIT	-21.86M
Earnings Per Share (EPS)	-$1.33

Full Income Statement

Balance Sheet

The company has $16.94 million in cash and $807,570 in debt, giving a net cash position of $16.13 million or $0.63 per share.

Cash & Cash Equivalents	16.94M
Total Debt	807,570
Net Cash	16.13M
Net Cash Per Share	$0.63
Equity (Book Value)	11.78M
Book Value Per Share	0.47
Working Capital	12.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.97 million and capital expenditures -$22,216, giving a free cash flow of -$18.99 million.

Operating Cash Flow	-18.97M
Capital Expenditures	-22,216
Free Cash Flow	-18.99M
FCF Per Share	-$0.74

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.04%
Shareholder Yield	-35.04%
Earnings Yield	-40.86%
FCF Yield	-35.93%

Analyst Forecast

The average price target for GANX is $7.75, which is 274.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.75
Price Target Difference	274.40%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	292.11%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GANX has an Altman Z-Score of -4.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.31
Piotroski F-Score	2